Pfizer Inc. is currently facing a multidistrict litigation in the United States involving approximately 400 lawsuits related to its contraceptive injection, Depo-Provera. The lawsuits allege that Pfizer failed to adequately warn women in the U.S. about the increased risk of developing brain tumors, specifically meningiomas, after prolonged use of the drug. This legal action comes in the wake of a study published in March 2024 by EPI-PHARE in the British Medical Journal, which found that women using Depo-Provera for over a year were 5.6 times more likely to develop intracranial meningiomas. Despite adding warning labels in Canada, the UK, and Europe, Pfizer has not issued similar warnings in the U.S. A Case Management Conference is scheduled for May 30 in Pensacola, Florida, as part of the proceedings. The litigation is being supported by the law firm Levin Papantonio.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.